JRSM > Volume 96, Number 4 > Pp. 175-179

This Article Full Text Full Text (PDF) Send a Quick Comment Alert me when this article is cited Alert me when Quick Comments are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nadar, S. Articles by Lip, G. Y H Search for Related Content PubMed PubMed Citation Social Bookmarking                      What's this?

Patients' understanding of anticoagulant therapy in a multiethnic population

Sunil Nadar MRCP   Nazneen Begum Bhupinder Kaur Sukhpreet Sandhu   Gregory Y H Lip MD FRCP  

University Department of Medicine, City Hospital, Dudley Road, Birmingham B18 7QH, UK

Correspondence to: Professor G Y H Lip E-mail: G.Y.H.LIP{at}bham.ac.uk

To investigate whether knowledge and perceptions of antithrombotic therapy differ between ethnic groups in the UK, we conducted a cross-sectional questionnaire survey of patients attending anticoagulation clinics in three Birmingham teaching hospitals. 180 consecutive patients were recruited—135 white European, 29 Indo-Asian, 16 Afro-Caribbean.

The average knowledge score was 5.5 out of 9, with no significant differences between the groups. Indo-Asians were significantly less likely than the other groups to know the name of the anticoagulant they were taking (warfarin) and Afro-Caribbeans to know the condition for which they were being anticoagulated. Few patients of any group were able to specify more than one side-effect of warfarin or the dose they were on. In logistic regression analysis the factors associated with a low score were age >61 years, having been born outside the UK, and the perception of difficulty in comprehension. Nearly half the Indo-Asians felt unable to understand what was said to them in the clinic, and 62% expressed a preference for a doctor of the same ethnic group.

Although there were no significant between-group differences, this study points to gaps in the knowledge of patients from ethnic minorities and to deficiencies in the provision of information. In patient education, these groups should receive special attention.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. E. Singer, G. W. Albers, J. E. Dalen, M. C. Fang, A. S. Go, J. L. Halperin, G. Y. H. Lip, and W. J. Manning Antithrombotic Therapy in Atrial Fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 546S - 592S. [Abstract] [Full Text] [PDF]

				A Choudhury and G Y H Lip How good is anticoagulation control in non-valvar atrial fibrillation? Observations on the elderly, ethnicity, patient perceptions, and understanding of AF thromboprophylaxis Heart, April 1, 2005; 91(4): 425 - 426. [Abstract] [Full Text] [PDF]

				N. J Davis, H. H Billett, H. W Cohen, and J. H Arnsten Impact of Adherence, Knowledge, and Quality of Life on Anticoagulation Control Ann. Pharmacother., April 1, 2005; 39(4): 632 - 636. [Abstract] [Full Text] [PDF]

				G Y H Lip, H Khan, A Bhatnagar, N Brahmabhatt, P Crook, and M K Davies Ethnic differences in patient perceptions of heart failure and treatment: the West Birmingham heart failure project Heart, September 1, 2004; 90(9): 1016 - 1019. [Abstract] [Full Text] [PDF]

				M. D. Ezekowitz and R. H. Falk The Increasing Need for Anticoagulant Therapy to Prevent Stroke in Patients With Atrial Fibrillation Mayo Clin. Proc., July 1, 2004; 79(7): 904 - 913. [Abstract] [PDF]

				H. Lambert and H. Wynne Patients' understanding of anticoagulant therapy J R Soc Med, November 1, 2003; 96(11): 572 - 572. [Full Text] [PDF]